Literature DB >> 213652

Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content.

J S Meyer, W C Bauer, B R Rao.   

Abstract

The S-phase fraction (SPF), defined as the number of cells per hundred that showed evidence of nuclear DNA synthesis detectable by autoradiography after in vitro incubation with tritiated thymidine, was measured in 170 primary, invasive carcinomas of the breast. Assay for estrogen receptor was performed on tissue from 129 carcinomas, and 34 were also assayed for progesterone receptor. The concentration of estradiol-17 beta was measured in the serum of 69 patients. All carcinomas were analyzed for a variety of histologic features and were classified into morphologic types. SPF were lognormally distributed and were negatively correlated with the patient's age and presence of estrogen receptor, but not with presence of progesterone receptor, size of the carcinoma, number of axillary nodal metastases, or concentration of estradiol-17 beta in serum. The SPFs of lobular, mucinous, and tubular carcinomas were consistently low (geometric mean 1.2, range 0.05 to 3.55), and the SPFs of medullary and atypical medullary carcinomas were consistently high (geometric mean 14.0, range 7.77 to 20.2), whereas carcinomas of other types (not otherwise specified) had an intermediate geometric mean (4.7) and a broad range (0.09 to 25.4). The carcinomas that were not otherwise specified could be divided into three groups with different geometric mean SPFs by nuclear morphologic criteria (1.2 for minimal atypicality, 3.5 for moderate, and 7.9 for severe). Therefore it is possible to sort breast carcinomas histologically into groups with low, intermediate, and high SPF. Correlations between SPF, estrogen receptor content, and microscopic morphology indicate the existence of distinctive subpopulations of breast carcinoma that may have epidemiologic and therapeutic importance.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 213652

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  18 in total

1.  Biological grading of breast cancer using antibodies to proliferating cells and other markers.

Authors:  S S Bacus; R Goldschmidt; D Chin; G Moran; D Weinberg; J W Bacus
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

2.  Prognostic value of morphometry in breast cancer.

Authors:  J P Baak; J C van der Linden; P J van Diest
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

Review 3.  Some aspects of the metastatic process.

Authors:  R L Carter
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

4.  Cell kinetics of histologic variants of in situ breast carcinoma.

Authors:  J S Meyer
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

5.  Transferrin receptor is inversely correlated with estrogen receptor in breast cancer.

Authors:  S E Tonik; J E Shindelman; H H Sussman
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

6.  Nucleolar grading of breast cancer. Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry.

Authors:  B Helpap
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 7.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

8.  Significance of the Tritiated Thymidine Labeling Index in breast cancers.

Authors:  K Araki; M Kimura; K Sakamoto; R Nishimura; M Akagi
Journal:  Jpn J Surg       Date:  1985-03

9.  Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors.

Authors:  J S Meyer; M Province
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

10.  Oestrogen receptors in human breast cancer. Problems of correlation with histopathological features.

Authors:  H S Poulsen; L Ozzello; J Andersen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.